National Cancer Institute Notice of Charter Renewal, 36078 [2014-14739]
Download as PDF
<![CDATA[
36078
Federal Register / Vol. 79, No. 122 / Wednesday, June 25, 2014 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Non-Competitive Program Expansion
Supplement for Ryan White HIV/AIDS
Part D Program, for Coordinated HIV
Services and Access for Women,
Infants, Children and Youth
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services.
ACTION: Notice of a Non-Competitive
Program Expansion Supplement to the
Ryan White HIV/AIDS Part D Program
for Coordinated HIV Services and
Access for Women, Infants, Children
and Youth.
AGENCY:
The Health Resources and
Services Administration (HRSA) will
issue a non-competitive program
expansion supplement to up to 115
Ryan White HIV/AIDS Part D program
grantees to support interventions that
will positively impact the HIV health
outcomes of women, infants, children,
and youth in communities where Part D
grantees are located. HRSA will provide
such one-time program expansion
supplemental awards for Part D
grantees, in an amount not to exceed the
lesser of $150,000 or 25 percent of each
fiscal year (FY) 2014 grant award.
SUPPLEMENTARY INFORMATION: No
additional information.
SUMMARY:
mstockstill on DSK4VPTVN1PROD with NOTICES
Authority: Section 2671 of the Public
Health Service (PHS) Act (42 U.S.C. 300ff–
71).
CFDA Number: 93.918.
Project period: The period of support
for this award is 11 months. The project
period is from August 1, 2014, through
June 30, 2015. This is explained below
in further detail.
Justification for the Exception to
Competition: The programmatic
supplements will support the women,
infants, children, and youth (WICY)
populations served by Part D grantees
and are designed to support
interventions that will positively impact
the HIV health outcomes in Part D
grantee communities. The Part D
Program Expansion Supplements will
fund HIV Care Continuum
interventions: (1) To enhance the
competencies and skills of the HIV
workforce (including health educators,
linkage/retention staff, nurses, case
managers/care coordinators, etc.)
located at the Part D grantee site and
partner sites to assist people living with
HIV/AIDS (PLWH) in engagement and
retention in HIV care; and (2) in
medication adherence to achieve viral
VerDate Mar<15>2010
18:01 Jun 24, 2014
Jkt 232001
load suppression. The numbers of
PLWH to be impacted include more
than 200,000 women, infants, children,
and youth that are served by current
Part D grantees. All currently funded
Part D grantees (115) are eligible for this
supplemental funding opportunity and
the maximum cumulative total awards
will not exceed $12,177,374.
To conform to HRSA’s efforts to align
project/budget period start dates with
the standard quarterly dates, in the FY
2012 re-competition of the entire Part D
program, the project period end date
was established as June 30, 2015. As a
result, the FY 2014 budget period for the
Part D program grantees will be 11
months from August 1, 2014, through
June 30, 2015.
John
Fanning, Senior Policy Advisor,
Division of Community HIV/AIDS
Programs, HAB, HRSA, 5600 Fishers
Lane, Rockville, MD 20857, by email
jfanning@hrsa.gov, or by phone at (301)
443–8367.
FOR FURTHER INFORMATION CONTACT:
Dated: June 16, 2014.
Mary K. Wakefield,
Administrator.
[FR Doc. 2014–14873 Filed 6–24–14; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director Notice of Charter
Renewal
In accordance with Title 41 of the
U.S. Code of Federal Regulations,
Section 102–3.65(a), notice is hereby
given that the Charter for the NIH
ADVISORY BOARD FOR CLINICAL
RESEARCH (ABCR) was renewed for an
additional two-year period on April 26,
2014.
It is determined that the ABCR is in
the public interest in connection with
the performance of duties imposed on
the National Institutes of Health by law,
and that these duties can best be
performed through the advice and
counsel of this group.
Inquires may be directed to Jennifer
Spaeth, Director, Office of Federal
Advisory Committee Policy, Office of
the Director, National Institutes of
Health, 6701 Democracy Boulevard,
Suite 1000, Bethesda, Maryland 20892
(Mail Code 4875), Telephone (301) 496–
2123, or spaethj@od.nih.gov.
PO 00000
Frm 00091
Fmt 4703
Sfmt 4703
Dated: June 19, 2014.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–14737 Filed 6–24–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute Notice of
Charter Renewal
In accordance with Title 41 of the
U.S. Code of Federal Regulations,
Section 102–3.65(a), notice is hereby
given that the Charter for the National
Cancer Institute Clinical Trials and
Translational Research Advisory
Committee was renewed for an
additional two-year period on April 14,
2014.
It is determined that the National
Cancer Institute Clinical Trials and
Translational Research Advisory
Committee is in the public interest in
connection with the performance of
duties imposed on the National Cancer
Institute and National Institutes of
Health by law, and that these duties can
best be performed through the advice
and counsel of this group.
Inquiries may be directed to Jennifer
Spaeth, Director, Office of Federal
Advisory Committee Policy, Office of
the Director, National Institutes of
Health, 6701 Democracy Boulevard,
Suite 1000, Bethesda, Maryland 20892
(Mail code 4875), Telephone (301) 496–
2123, or spaethj@od.nih.gov.
Dated: June 19, 2014.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–14739 Filed 6–24–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of Health Assessment and
Translation Webinar on Lessons
Learned in Application of the OHAT
Framework for Systematic Review and
Evidence Integration to Case Studies;
Notice of Public Webinar and
Registration Information
The National Toxicology
Program (NTP) announces a public
webinar, ‘‘Lessons Learned in
Application of the Office of Health
Assessment and Translation (OHAT)
Framework for Systematic Review and
SUMMARY:
E:\FR\FM\25JNN1.SGM
25JNN1
]]>Agencies
[Federal Register Volume 79, Number 122 (Wednesday, June 25, 2014)]
[Notices]
[Page 36078]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-14739]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute Notice of Charter Renewal
In accordance with Title 41 of the U.S. Code of Federal
Regulations, Section 102-3.65(a), notice is hereby given that the
Charter for the National Cancer Institute Clinical Trials and
Translational Research Advisory Committee was renewed for an additional
two-year period on April 14, 2014.
It is determined that the National Cancer Institute Clinical Trials
and Translational Research Advisory Committee is in the public interest
in connection with the performance of duties imposed on the National
Cancer Institute and National Institutes of Health by law, and that
these duties can best be performed through the advice and counsel of
this group.
Inquiries may be directed to Jennifer Spaeth, Director, Office of
Federal Advisory Committee Policy, Office of the Director, National
Institutes of Health, 6701 Democracy Boulevard, Suite 1000, Bethesda,
Maryland 20892 (Mail code 4875), Telephone (301) 496-2123, or
spaethj@od.nih.gov.
Dated: June 19, 2014.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-14739 Filed 6-24-14; 8:45 am]
BILLING CODE 4140-01-P
